Frequency and Reasons for Return to the Primary Acute Care Service Among Patients With Lymphoma Undergoing Inpatient Rehabilitation

PM and R

Volumn 6, Issue 7, 2014, Pages 629-634

  Fu, Jack B ^a   Lee, Jay ^b   Smith, Dennis W ^b   Shin, Ki ^a   Guo, Ying ^a   Bruera, Eduardo ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER REHABILITATION; CREATININE BLOOD LEVEL; EMERGENCY CARE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; SEX DIFFERENCE; VERY ELDERLY; YOUNG ADULT; EMERGENCY HEALTH SERVICE; FOLLOW UP; HOSPITAL READMISSION; INCIDENCE; NEOPLASM RECURRENCE, LOCAL; PRIMARY HEALTH CARE; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; EMERGENCY SERVICE, HOSPITAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INPATIENTS; LYMPHOMA; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT READMISSION; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84904641749     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2013.12.009     Document Type: Article

References (22)

1. Siefert M.L. Fatigue, pain, and functional status during outpatient chemotherapy. Oncol Nurs Forum 2010, 37:E114-E123.
2. Dimeo F.C. Effects of exercise on cancer-related fatigue. Cancer 2001, 92:1689-1693.
3. Wedding U., Rohrig B., Klippstein A., Fricke H.J., Sayer H.G., Hoffken K. Impairment in functional status and survival in patients with acute myeloid leukaemia. JCancer Res Clin Oncol 2006, 132:665-671.
4. Bertheussen G.F., Kaasa S., Hokstad A., et al. Feasibility and changes in symptoms and functioning following inpatient cancer rehabilitation. Acta Oncol 2012, 51:1070-1080.
5. Guo Y., Shin K.Y., Hainley S., Bruera E., Palmer J.L. Inpatient rehabilitation improved functional status in asthenic patients with solid and hematologic malignancies. Am J Phys Med Rehabil 2011, 90:265-271.
6. Carney M.L., Ullrich P., Esselman P. Early unplanned transfers from inpatient rehabilitation. Am J Phys Med Rehabil 2006, 85:453-460. quiz 461-453.
7. Schneider J.C., Gerrard P., Goldstein R., et al. Predictors of transfer from rehabilitation to acute care in burn injuries. JTrauma Acute Care Surg 2012, 73:1596-1601.
8. Stineman M.G., Ross R., Maislin G., Fiedler R.C., Granger C.V. Risks of acute hospital transfer and mortality during stroke rehabilitation. Arch Phys Med Rehabil 2003, 84:712-718.
9. Deshpande A.A., Millis S.R., Zafonte R.D., Hammond F.M., Wood D.L. Risk factors for acute care transfer among traumatic brain injury patients. Arch Phys Med Rehabil 1997, 78:350-352.
10. Hung J.W., Tsay T.H., Chang H.W., Leong C.P., Lau Y.C. Incidence and risk factors of medical complications during inpatient stroke rehabilitation. Chang Gung Med J 2005, 28:31-38.
11. Alam E., Wilson R.D., Vargo M.M. Inpatient cancer rehabilitation: A retrospective comparison of transfer back to acute care between patients with neoplasm and other rehabilitation patients. Arch Phys Med Rehabil 2008, 89:1284-1289.
12. Guo Y., Persyn L., Palmer J.L., Bruera E. Incidence of and risk factors for transferring cancer patients from rehabilitation to acute care units. Am J Phys Med Rehabil 2008, 87:647-653.
13. Fu J.B., Lee J., Smith D.W., Guo Y., Bruera E. Return to primary service among bone marrow transplant rehabilitation inpatients: An index for predicting outcomes. Arch Phys Med Rehabil 2013, 94:356-361.
14. Fu J.B., Lee J., Smith D.W., Bruera E. Frequency and reasons for return to acute care in patients with leukemia undergoing inpatient rehabilitation: A preliminary report. Am J Phys Med Rehabil 2013, 92:215-222.
15. Elmi S., McEwen S. Poster 145: Factors associated with unplanned discharge to acute care in an inpatient oncology rehabilitation population. Arch Phys Med Rehabil 1733, 201:92.
16. Hasenclever D., Diehl V. Aprognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. NEngl J Med 1998, 339:1506-1514.
17. Jäger U., Fridrik M., Zeitlinger M., et al. Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response. Haematologica 2012, 97:1431-1438. Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT) investigators.
18. Armand P., Welch S., Kim H.T., et al. Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era. Br J Haematol 2013, 160:608-617.
19. Tiede C., Maecker-Kolhoff B., Klein C., Kreipe H., Hussein K. Risk factors and prognosis in T-cell posttransplantation lymphoproliferative diseases: Reevaluation of 163 cases. Transplantation 2013, 95:479-488.
20. Cheah C.Y., George A., Giné E., et al. Central nervous system involvement in mantle cell lymphoma: Clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network. Ann Oncol 2013, 24:2119-2123. for the European Mantle Cell Lymphoma Network.
21. Lister T.A., Crowther D., Sutcliffe S.B., et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. JClin Oncol 1989, 7:1630-1636.
22. Hamlin P.A., Zelenetz A.D., Kewalramani T., et al. Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma. Blood 2003, 102:1989-1996.